PharmaLifeSciences 2024: Advancements in Cell and Gene Therapy
June 11, 2024
Navigate training, therapies, pricing strategies, and pharmacogenomics integration.
Attendees are invited to a comprehensive exploration of cell and gene therapy advancements. This session will explore the strategic training of healthcare professionals, the evolving landscape of therapies for solid tumors, and the nuanced considerations in pricing strategies for these innovative products. The discussion will also highlight the broader implications of integrating pharmacogenomics and guiding decisions in precision medicine. Participants will gain valuable insights into the multifaceted aspects shaping the future of healthcare innovation.
You will soon be able to register for free and gain access to live webinars, fireside chats and keynote presentations from the world’s leading innovators, vendors and evangelists.
June 11, 2024
Audience
MDs, Heads, EVPs, SVPs, VPs, Directors, Managers, Practitioners, and Consultants within:
Pharma / Life Sciences / Medicine
Digital CMC / Digital Technologies
Data & Analytics / Strategy
Business Operations
Healthcare Operations / Healthcare Innovation
Medical Value
Pharmacogenomics
Cell & Gene Therapy
Healthcare Pricing & Strategy
Previous Speaking and Attending Companies
AbbVie Inc., Academy of Managed Care Pharmacy, Aetna Inc, Alcon Laboratories, Inc., Aliados Health, Alkermes, Inc., Alnylam Pharmaceuticals, Inc., Astellas Pharma Inc., AstraZeneca Plc, Atrium Health, Avalere Health LLC, Ballad Health, Bangkok Hospital, Bausch Health, Baxter International, Bayer AG, Benefis Healthcare, Biossil, BJC HealthCare, Blue Cross and Blue Shield of North Carolina, Bluestream Health, Boston Medical Center, Bristol-Myers Squibb Company, CancerCare Manitoba Foundation Inc., Care2Care International, Catalia Health, Cepheid Inc., Centers for Disease Control and Prevention
Children’s Medical Center, Clinuvel Pharmaceuticals Ltd, Colorado Pharmacy Society, CommonSpirit Health, Duke University, EagleForce Health LLC, Essentia Health, Free Market Health, Genentech, Inc., Gold Coast Health Plan, Grifols Inc., Guidewell Hawler Medical University, Healthcentric Advisors, Highmark Health, Hoffmann-La Roche Inc., Hudson Valley Heart Center, Indiana University Health, Intermountain Health Care, InC., J.P. Morgan & Co., Kaiser Permanente, Lupin Pharmaceuticals, M&T Bank, Marathon Health, Mayo Foundation for Medical Education & Research
Medical Research Council, Medicare Payment Advisory Commission, Medstar, Merge Healthcare, Morgan Stanley & Co., Mount Sinai Hospital, MountainStar Healthcare Network, MVP Health Care Inc., National Institutes of Health, National Nurses In Business Association, Inc., naviHealth, New York University Langone Medical Center, Northwell Health, Ohio Pharmacists Association, Oklahoma Health Care Authority, Oklahoma State University, Pacira Pharmaceuticals, Palomar Health, Penn Medicine, Penn State Health, PerkinElmer, Pharmaceutical Care Management Association
PrimeWest Health, Renown Health Foundation Rhode Island Department of Health, Sabio Health, Sanford Health, Story Health, St Petersburg State University, Strathmore University, Superior Biologics, Tabia Health, Taiho Oncology, Inc., Takeda Pharmaceutical Company, Texas Tech University, The Advisory Board Company, The Merck Group, The Wellness Centre, UnitedHealthcare, University of Michigan, University of New Hampshire, University of North Carolina at Chapel Hill, University of Pittsburgh Medical Center, Walgreens, West Pharmaceutical Services Inc., WEX Health, and more!